TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018
Feature | TCT | September 14, 2018 | Dave Fornell, Editor

The volume of information attendees receive at the annual...

Abbott Receives FDA Approval for Third-Generation MitraClip Device
Technology | Heart Valve Technology | July 18, 2018

July 18, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-...

William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.

William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support. 

Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor

About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...

LivaNova Receives FDA Clearance for Memo 4D Semi-Rigid Mitral Annuloplasty Ring
Technology | Annuloplasty Rings | June 15, 2018

June 15, 2018 — LivaNova PLC announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...

FDA Approves 200, 250 Millimeter In.Pact Admiral Drug Coated Balloons
Technology | Drug-Eluting Balloons | June 15, 2018

June 15, 2018 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm...

Abbott's Xience Sierra Stent Receives FDA Approval
Technology | Stents Drug Eluting | May 25, 2018

May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience...

An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate vessel segments that are occluded and not visible on angiography alone.

An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate chronic total occlusion vessel segments that are occluded and not visible on angiography alone. 

Feature | Chronic Total Occlusion (CTO) | February 20, 2018 | Dave Fornell

One of the recent hot topics in interventional cardiology has been how operators can use new tools and techniques to...

Videos | Radial Access | February 16, 2018

The father of transradial artery access, Ferdinand Kiemeneij, M.D., Ph.D., interventional cardiologist, The...

Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve has been approved with CE mark for use in Europe.
Feature | Heart Valve Technology | February 15, 2018

February 15, 2018 — Edwards Lifesciences Corp. has received European CE mark clearance for its self-expanding...

Biotronik Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in Clinical Practice
News | Stents Drug Eluting | January 25, 2018

January 25, 2018 – Data presented at the Biotronik-sponsored...

Elixir Medical Corporation Unveils Transformational DynamX Stent Featuring Adaptive Segments that Uncage the Stented Artery
News | Stents | January 25, 2018

January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling...

A live Corevalve TAVR case in the main arena at TCT 2017. Structural heart has moved from a science fiction discussion in future technology sessions at TCT a decade ago to now being a major portion of what the conference discusses for today's clinical practice.

A live CoreValve TAVR case in the main arena at TCT 2017. Structural heart has moved from a science fiction discussion in future technology sessions at TCT a decade ago to now being a major portion of what the conference discusses for today's clinical practice.

Blog | TCT | January 18, 2018

Here is a list of what I think were some of the top interventional technologies discussed at the 2017 Transcatheter...

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS) bioabsorbable stent.

The Abbott Absorb Bioresorbable Vascular Scaffold (BVS).

Feature | Stents Drug Eluting | January 17, 2018 | Dave Fornell

There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or...

Videos | Cath Lab | January 04, 2018

Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif...

Overlay Init